These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 23245802)
1. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. Liu JJ; Zhang H; Sun J; Wang ZC; Yang YS; Li DD; Zhang F; Gong HB; Zhu HL Bioorg Med Chem; 2012 Oct; 20(20):6089-96. PubMed ID: 22985957 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
4. Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. Yang W; Hu Y; Yang YS; Zhang F; Zhang YB; Wang XL; Tang JF; Zhong WQ; Zhu HL Bioorg Med Chem; 2013 Mar; 21(5):1050-63. PubMed ID: 23391364 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors. Qiu KM; Wang HH; Wang LM; Luo Y; Yang XH; Wang XM; Zhu HL Bioorg Med Chem; 2012 Mar; 20(6):2010-8. PubMed ID: 22361272 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors. Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022 [TBL] [Abstract][Full Text] [Related]
11. Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. Yang YS; Li QS; Sun S; Zhang YB; Wang XL; Zhang F; Tang JF; Zhu HL Bioorg Med Chem; 2012 Oct; 20(20):6048-58. PubMed ID: 22985962 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Lv PC; Li HQ; Sun J; Zhou Y; Zhu HL Bioorg Med Chem; 2010 Jul; 18(13):4606-14. PubMed ID: 20627597 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Li X; Lu X; Xing M; Yang XH; Zhao TT; Gong HB; Zhu HL Bioorg Med Chem Lett; 2012 Jun; 22(11):3589-93. PubMed ID: 22572580 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors. Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. Xu YY; Cao Y; Ma H; Li HQ; Ao GZ Bioorg Med Chem; 2013 Jan; 21(2):388-94. PubMed ID: 23245570 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors. Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors. Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006 [TBL] [Abstract][Full Text] [Related]
19. Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies. Shahavar Sulthana S; Arul Antony S; Balachandran C; Syed Shafi S Bioorg Med Chem Lett; 2015 Jul; 25(14):2753-7. PubMed ID: 26028159 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]